Line 1: |
Line 1: |
− | ==Myeloid proliferations and neoplasms== | + | ==Myeloproliferative Neoplasms (MPN) ([[HAEM4:Myeloproliferative Neoplasms (MPN)|Overview Page Link]])== |
| | | |
− | '''Myeloid precursor lesions'''
| + | *[[HAEM4:Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] |
− | ''Clonal Haematopoiesis''
| + | *[[HAEM4:Chronic Neutrophilic Leukemia (CNL)]] |
− | - [[HAEM4:Clonal haematopoiesis]]
| + | *[[HAEM4:Polycythemia Vera (PV)]] |
− | - [[HAEM4:Clonal cytopenias of undetermined significance]]
| + | *[[HAEM4:Primary Myelofibrosis (PMF)]] |
| + | *[[HAEM4:Essential Thrombocythemia (ET)]] |
| + | *[[HAEM4:Chronic Eosinophilic Leukemia, Not Otherwise Specified]] |
| + | *[[HAEM4:Myeloproliferative Neoplasm (MPN), Unclassifiable]] |
| | | |
− | '''Myeloproliferative neoplasms
| + | ==Mastocytosis ([[HAEM4:Mastocytosis|Overview Page Link]])== |
− | ''Myeloproliferative neoplasms''
| |
− | - [[HAEM4:Chronic myeloid leukaemia]]
| |
− | - [[HAEM4:Chronic neutrophilic leukaemia]]
| |
− | - [[HAEM4:Chronic eosinophilic leukaemia]]
| |
− | - [[HAEM4:Polycythaemia vera]]
| |
− | - [[HAEM4:Essential thrombocythaemia]]
| |
− | - [[HAEM4:Primary myelofibrosis]]
| |
− | - [[HAEM4:Juvenile myelomonocytic leukaemia]]
| |
− | - [[HAEM4:Myeloproliferative neoplasm, NOS]]
| |
| | | |
− | '''Mastocytosis'''
| + | *[[HAEM4:Cutaneous Mastocytosis]] |
− | - [[HAEM4:Cutaneous mastocytosis]]
| + | *[[HAEM4:Systemic Mastocytosis]] |
− | - [[HAEM4:Systemic mastocytosis]]
| + | *[[HAEM4:Mast Cell Sarcoma]] |
− | - [[HAEM4:Mast cell sarcoma]]
| |
| | | |
− | '''Myelodysplastic neoplasms'''
| + | ==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ([[HAEM4:Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2|Overview Page Link]])== |
− | ''Myelodysplastic neoplasms, with defining genetic abnormalities''
| |
− | - [[HAEM4:Myelodysplastic neoplasm with low blasts and 5q deletion]]
| |
− | - [[HAEM4:Myelodysplastic neoplasm with low blasts and SF3B1 mutation]]
| |
− | - [[HAEM4:Myelodysplastic neoplasm with biallelic TP53 inactivation]]
| |
− | ''Myelodysplastic neoplasms, morphologically defined''
| |
− | - [[HAEM4:Myelodysplastic neoplasm with low blasts]]
| |
− | - [[HAEM4:Myelodysplastic neoplasm, hypoplastic]]
| |
− | - [[HAEM4:Myelodysplastic neoplasm with increased blasts]]
| |
− | ''Myelodysplastic neoplasms of childhood''
| |
− | - [[HAEM4:Childhood myelodysplastic neoplasm with low blasts]]
| |
− | - [[HAEM4:Childhood myelodysplastic neoplasm with increased blasts]]
| |
| | | |
− | '''Myelodysplastic/myeloproliferative neoplasms'''
| + | *[[HAEM4:Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]] |
− | - [[HAEM4:Chronic myelomonocytic leukaemia]]
| + | *[[HAEM4:Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement]] |
− | - [[HAEM4:Myelodysplastic/myeloproliferative neoplasm with neutrophilia]]
| + | *[[HAEM4:Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement]] |
− | - [[HAEM4:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]]
| + | *[[HAEM4:Myeloid/Lymphoid Neoplasms with PCM1-JAK2]] |
− | - [[HAEM4:Myelodysplastic/myeloproliferative neoplasm, NOS]]
| |
| | | |
− | '''Acute myeloid leukaemia'''
| + | ==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ([[HAEM4:Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Overview Page Link]])== |
− | ''Acute myeloid leukaemia with defining genetic abnormalities''
| |
− | - [[HAEM4:Acute promyelocytic leukaemia with PML::RARA fusion]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with CBFB::MYH11 fusion]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with DEK::NUP214 fusion]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with RBM15::MRTFA fusion]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with BCR::ABL1 fusion]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with KMT2A rearrangement]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with MECOM rearrangement]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with NUP98 rearrangement]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with NPM1 mutation]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with CEBPA mutation]]
| |
− | - [[HAEM4:Acute myeloid leukaemia, myelodysplasia-related]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with other defined genetic alterations]]
| |
− | ''Acute myeloid leukaemia, defined by differentiation''
| |
− | - [[HAEM4:Acute myeloid leukaemia with minimal differentiation]]
| |
− | - [[HAEM4:Acute myeloid leukaemia without maturation]]
| |
− | - [[HAEM4:Acute myeloid leukaemia with maturation]]
| |
− | - [[HAEM4:Acute basophilic leukaemia]]
| |
− | - [[HAEM4:Acute myelomonocytic leukaemia]]
| |
− | - [[HAEM4:Acute monocytic leukaemia]]
| |
− | - [[HAEM4:Acute erythroid leukaemia]]
| |
− | - [[HAEM4:Acute megakaryoblastic leukaemia]]
| |
− | ''Myeloid sarcoma''
| |
− | - [[HAEM4:Myeloid sarcoma]]
| |
| | | |
− | '''Myeloid neoplasms, secondary'''
| + | *[[HAEM4:Chronic Myelomonocytic Leukemia (CMML)]] |
− | ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions''
| + | *[[HAEM4:Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative]] |
− | - [[HAEM4:Myeloid neoplasm post cytotoxic therapy]]
| + | *[[HAEM4:Juvenile Myelomonocytic Leukemia (JMML)]] |
− | - [[HAEM4:Myeloid neoplasms associated with germline predisposition]]
| + | *[[HAEM4:Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]] |
− | - [[HAEM4:Myeloid proliferations associated with Down syndrome]]
| + | *[[HAEM4:Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] |
| | | |
− | '''Myeloid/lymphoid neoplasms'''
| + | ==Myelodysplastic Syndromes (MDS) ([[HAEM4:Myelodysplastic Syndromes (MDS)|Overview Page Link]])== |
− | ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement''
| |
− | - [[HAEM4:Myeloid/lymphoid neoplasm with PDGFRA rearrangement]]
| |
− | - [[HAEM4:Myeloid/lymphoid neoplasm with PDGFRB rearrangement]]
| |
− | - [[HAEM4:Myeloid/lymphoid neoplasm with FGFR1 rearrangement]]
| |
− | - [[HAEM4:Myeloid/lymphoid neoplasm with JAK2 rearrangement]]
| |
− | - [[HAEM4:Myeloid/lymphoid neoplasm with FLT3 rearrangement]]
| |
− | - [[HAEM4:Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]]
| |
− | - [[HAEM4:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]]
| |
| | | |
− | '''Acute leukaemias of mixed or ambiguous lineage'''
| + | *[[HAEM4:Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] |
− | ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities''
| + | *[[HAEM4:Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]] |
− | - [[HAEM4:Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]]
| + | *[[HAEM4:Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]] |
− | - [[HAEM4:Mixed-phenotype acute leukaemia with KMT2A rearrangement]]
| + | *[[HAEM4:Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]] |
− | - [[HAEM4:Acute leukaemia of ambiguous lineage with other defined genetic alterations ]]
| + | *[[HAEM4:Myelodysplastic Syndrome (MDS) with Excess Blasts|MDS with Excess Blasts]] |
− | ''Acute leukaemia of ambiguous lineage, immunophenotypically defined''
| + | *[[HAEM4:Myelodysplastic Syndrome (MDS) with Isolated del(5q)|MDS with Isolated del(5q)]] |
− | - [[HAEM4:Mixed-phenotype acute leukaemia, B/myeloid]]
| + | *[[HAEM4:Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]] |
− | - [[HAEM4:Mixed-phenotype acute leukaemia, T/myeloid]]
| + | *[[HAEM4:Refractory Cytopenia of Childhood]] |
− | - [[HAEM4:Mixed-phenotype acute leukaemia, rare types]]
| |
− | - [[HAEM4:Acute leukaemia of ambiguous lineage, NOS]]
| |
− | - [[HAEM4:Acute undifferentiated leukaemia]]
| |
− | ==Histiocytic/Dendritic cell neoplasms==
| |
| | | |
− | '''Plasmacytoid dendritic cell neoplasms'''
| + | ==Myeloid Neoplasms with Germline Predisposition ([[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
− | ''Plasmacytoid dendritic cell neoplasms''
| |
− | - [[HAEM4:Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]]
| |
− | - [[HAEM4:Blastic plasmacytoid dendritic cell neoplasm]]
| |
| | | |
− | '''Langerhans cell and other dendritic cell neoplasms'''
| + | *[[HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation]] |
− | ''Langerhans cells neoplasms''
| + | *[[HAEM4:Myeloid Neoplasms with Germline DDX41 Mutation]] |
− | - [[HAEM4:Langerhans cell histiocytosis]]
| + | *[[HAEM4:Myeloid Neoplasms with Germline RUNX1 Mutation]] |
− | - [[HAEM4:Langerhans cell sarcoma]]
| + | *[[HAEM4:Myeloid Neoplasms with Germline ANKRD26 Mutation]] |
− | ''Other dendritic cell neoplasms''
| + | *[[HAEM4:Myeloid Neoplasms with Germline ETV6 Mutation]] |
− | - [[HAEM4:Indeterminate dendritic cell tumour]]
| + | *[[HAEM4:Myeloid Neoplasms with Germline GATA2 Mutation]] |
− | - [[HAEM4:Interdigitating dendritic cell sarcoma]]
| |
| | | |
− | '''Histiocyte/macrophage neoplasms'''
| + | ==Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms ([[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
− | ''Histiocytic neoplasms''
| |
− | - [[HAEM4:Juvenile xanthogranuloma]]
| |
− | - [[HAEM4:Erdheim-Chester disease]]
| |
− | - [[HAEM4:Rosai-Dorfman Disease]]
| |
− | - [[HAEM4:ALK-positive histiocytosis]]
| |
− | - [[HAEM4:Histiocytic sarcoma]]
| |
− | ==B-cell lymphoid proliferations and lymphomas==
| |
| | | |
− | '''Tumour like lesions with B-cell predominance'''
| + | *[[HAEM4:Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] |
− | - [[HAEM4:Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]]
| |
− | - [[HAEM4:IgG4-related disease]]
| |
− | - [[HAEM4:Unicentric Castleman disease]]
| |
− | - [[HAEM4:Idiopathic multicentric Castleman disease]]
| |
− | - [[HAEM4:KSHV/HHV8-associated multicentric Castleman disease]]
| |
| | | |
− | '''Precursor B-cell neoplasms'''
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]] |
− | ''B-lymphoblastic leukaemias/lymphomas''
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] |
− | - [[HAEM4:B-lymphoblastic leukaemia/lymphoma]]
| + | - [[HAEM4:Acute Promyelocytic Leukemia (APL) with PML-RARA]] |
− | - [[HAEM4:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3|AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]] |
− | - [[HAEM4:B-lymphoblastic leukaemia/lymphoma with hypodiploidy]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214|AML with t(6;9)(p23;q34.1); DEK-NUP214]] |
− | - [[HAEM4:B-lymphoblastic leukaemia/lymphoma with iAMP21]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM|AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]] |
− | - [[HAEM4:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1|AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]] |
− | - [[HAEM4:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with BCR-ABL1|AML with BCR-ABL1]] |
− | - [[HAEM4:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with Mutated NPM1|AML with Mutated NPM1]] |
− | - [[HAEM4:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA|AML with Biallelic Mutations of CEBPA]] |
− | - [[HAEM4:B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]] |
− | - [[HAEM4:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion]]
| |
− | - [[HAEM4:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion ]]
| |
− | - [[HAEM4:B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion]]
| |
− | - [[HAEM4:B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]]
| |
− | - [[HAEM4:B-lymphoblastic leukaemia/lymphoma, NOS]]
| |
| | | |
− | '''Mature B-cell neoplasms'''
| + | *[[HAEM4:Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes|AML with Myelodysplasia-Related Changes]] |
− | ''Pre-neoplastic and neoplastic small lymphocytic proliferations ''
| |
− | - [[HAEM4:Monoclonal B-cell lymphocytosis]]
| |
− | - [[HAEM4:Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
| |
− | ''Splenic B-cell lymphomas and leukaemias''
| |
− | - [[HAEM4:Hairy cell leukaemia]]
| |
− | - [[HAEM4:Splenic marginal zone lymphoma]]
| |
− | - [[HAEM4:Splenic diffuse red pulp small B-cell lymphoma]]
| |
− | - [[HAEM4:Splenic B-cell lymphoma/leukaemia with prominent nucleoli]]
| |
− | ''Lymphoplasmacytic lymphoma''
| |
− | - [[HAEM4:Lymphoplasmacytic lymphoma]]
| |
− | ''Marginal zone lymphoma''
| |
− | - [[HAEM4:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]]
| |
− | - [[HAEM4:Primary cutaneous marginal zone lymphoma ]]
| |
− | - [[HAEM4:Nodal marginal zone lymphoma]]
| |
− | - [[HAEM4:Paediatric nodal marginal zone lymphoma]]
| |
− | ''Follicular lymphoma''
| |
− | - [[HAEM4:In situ follicular B-cell neoplasm]]
| |
− | - [[HAEM4:Follicular lymphoma]]
| |
− | - [[HAEM4:Paediatric-type follicular lymphoma]]
| |
− | - [[HAEM4:Duodenal-type follicular lymphoma]]
| |
− | ''Cutaneous follicle centre lymphoma''
| |
− | - [[HAEM4:Primary cutaneous follicle centre lymphoma]]
| |
− | ''Mantle cell lymphoma''
| |
− | - [[HAEM4:In situ mantle cell neoplasm]]
| |
− | - [[HAEM4:Mantle cell lymphoma]]
| |
− | - [[HAEM4:Leukaemic non-nodal mantle cell lymphoma]]
| |
− | ''Transformations of indolent B-cell lymphomas''
| |
− | - [[HAEM4:Transformations of indolent B-cell lymphomas]]
| |
− | ''Large B-cell lymphomas''
| |
− | - [[HAEM4:Diffuse large B-cell lymphoma, NOS]]
| |
− | - [[HAEM4:T-cell/histiocyte-rich large B-cell lymphoma]]
| |
− | - [[HAEM4:Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements]]
| |
− | - [[HAEM4:ALK-positive large B-cell lymphoma]]
| |
− | - [[HAEM4:Large B-cell lymphoma with IRF4 rearrangement]]
| |
− | - [[HAEM4:High grade B-cell lymphoma with 11q aberrations]]
| |
− | - [[HAEM4:Lymphomatoid granulomatosis]]
| |
− | - [[HAEM4:EBV-positive diffuse large B-cell lymphoma]]
| |
− | - [[HAEM4:Diffuse large B-cell lymphoma associated with chronic inflammation]]
| |
− | - [[HAEM4:Fibrin-associated large B-cell lymphoma]]
| |
− | - [[HAEM4:Fluid overload-associated large B-cell lymphoma]]
| |
− | - [[HAEM4:Plasmablastic lymphoma]]
| |
− | - [[HAEM4:Primary large B-cell lymphoma of immune-privileged sites]]
| |
− | - [[HAEM4:Primary cutaneous diffuse large B-cell lymphoma, leg type]]
| |
− | - [[HAEM4:Intravascular large B-cell lymphoma]]
| |
− | - [[HAEM4:Primary mediastinal large B-cell lymphoma]]
| |
− | - [[HAEM4:Mediastinal grey zone lymphoma]]
| |
− | - [[HAEM4:High-grade B-cell lymphoma, NOS]]
| |
− | ''Burkitt lymphoma''
| |
− | - [[HAEM4:Burkitt lymphoma]]
| |
− | ''KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas''
| |
− | - [[HAEM4:Primary effusion lymphoma]]
| |
− | - [[HAEM4:KSHV/HHV8-positive diffuse large B-cell lymphoma]]
| |
− | - [[HAEM4:KSHV/HHV8-positive germinotropic lymphoproliferative disorder]]
| |
− | ''Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation''
| |
− | - [[HAEM4:Hyperplasias arising in immune deficiency/dysregulation]]
| |
− | - [[HAEM4:Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation ]]
| |
− | - [[HAEM4:EBV-positive mucocutaneous ulcer]]
| |
− | - [[HAEM4:Lymphomas arising in immune deficiency / dysregulation ]]
| |
− | - [[HAEM4:Inborn error of immunity-associated lymphoid proliferations and lymphomas]]
| |
| | | |
− | '''Hodgkin lymphoma'''
| + | *[[HAEM4:Therapy-Related Myeloid Neoplasms]] |
− | - [[HAEM4:Classic Hodgkin lymphoma ]]
| |
− | - [[HAEM4:Nodular lymphocyte predominant Hodgkin lymphoma]]
| |
| | | |
− | '''Plasma cell neoplasms and other diseases with paraproteins'''
| + | *[[HAEM4:Acute Myeloid Leukemia (AML), Not Otherwise Specified|AML, Not Otherwise Specified]] |
− | ''Monoclonal gammopathies''
| |
− | - [[HAEM4:Cold agglutinin disease ]]
| |
− | - [[HAEM4:IgM monoclonal gammopathy of undetermined significance]]
| |
− | - [[HAEM4:Non-IgM monoclonal gammopathy of undetermined significance]]
| |
− | - [[HAEM4:Monoclonal gammopathy of renal significance]]
| |
− | ''Diseases with monoclonal immunoglobulin deposition''
| |
− | - [[HAEM4:Immunoglobulin-related (AL) amyloidosis]]
| |
− | - [[HAEM4:Monoclonal immunoglobulin deposition disease]]
| |
− | ''Heavy chain diseases''
| |
− | - [[HAEM4:Mu heavy chain disease]]
| |
− | - [[HAEM4:Gamma heavy chain disease]]
| |
− | - [[HAEM4:Alpha heavy chain disease]]
| |
− | ''Plasma cell neoplasms''
| |
− | - [[HAEM4:Plasmacytoma]]
| |
− | - [[HAEM4:Plasma cell myeloma / multiple myeloma]]
| |
− | - [[HAEM4:Plasma cell neoplasms with associated paraneoplastic syndrome]]
| |
− | ==T-cell and NK-cell lymphoid proliferations and lymphomas==
| |
| | | |
− | '''Tumour-like lesions with T-cell predominance'''
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with Minimal Differentiation|AML with Minimal Differentiation]] |
− | - [[HAEM4:Kikuchi-Fujimoto disease]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) without Maturation|AML without Maturation]] |
− | - [[HAEM4:Autoimmune lymphoproliferative syndrome]]
| + | - [[HAEM4:Acute Myeloid Leukemia (AML) with Maturation|AML with Maturation]] |
− | - [[HAEM4:Indolent T-lymphoblastic proliferation]]
| + | - [[HAEM4:Acute Myelomonocytic Leukemia]] |
| + | - [[HAEM4:Acute Monoblastic and Monocytic Leukemia]] |
| + | - [[HAEM4:Pure Erythroid Leukemia]] |
| + | - [[HAEM4:Acute Megakaryoblastic Leukemia (AMKL)]] |
| + | - [[HAEM4:Acute Basophilic Leukemia]] |
| + | - [[HAEM4:Acute Panmyelosis with Myelofibrosis]] |
| | | |
− | '''Precursor T-cell neoplasms'''
| + | *[[HAEM4:Myeloid Sarcoma]] |
− | ''T-lymphoblastic leukaemia / lymphoma''
| |
− | - [[HAEM4:T-lymphoblastic leukaemia / lymphoma, NOS]]
| |
− | - [[HAEM4:Early T-precursor lymphoblastic leukaemia / lymphoma ]]
| |
| | | |
− | '''Mature T-cell and NK-cell neoplasms'''
| + | *[[HAEM4:Myeloid Proliferations Associated with Down Syndrome]] |
− | ''Mature T-cell and NK-cell leukaemias''
| |
− | - [[HAEM4:T-prolymphocytic leukaemia]]
| |
− | - [[HAEM4:T-large granular lymphocytic leukaemia]]
| |
− | - [[HAEM4:NK-large granular lymphocytic leukaemia]]
| |
− | - [[HAEM4:Adult T-cell leukaemia/lymphoma]]
| |
− | - [[HAEM4:Sezary syndrome]]
| |
− | - [[HAEM4:Aggressive NK-cell leukaemia]]
| |
− | ''Primary cutaneous T-cell lymphoid proliferations and lymphomas''
| |
− | - [[HAEM4:Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]]
| |
− | - [[HAEM4:Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder]]
| |
− | - [[HAEM4:Mycosis fungoides]]
| |
− | - [[HAEM4:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis]]
| |
− | - [[HAEM4:Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma]]
| |
− | - [[HAEM4:Subcutaneous panniculitis-like T-cell lymphoma]]
| |
− | - [[HAEM4:Primary cutaneous gamma/delta T-cell lymphoma]]
| |
− | - [[HAEM4:Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]]
| |
− | - [[HAEM4:Primary cutaneous peripheral T-cell lymphoma, NOS]]
| |
− | ''Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas''
| |
− | - [[HAEM4:Indolent T-cell lymphoma of the gastrointestinal tract]]
| |
− | - [[HAEM4:Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract]]
| |
− | - [[HAEM4:Enteropathy-associated T-cell lymphoma]]
| |
− | - [[HAEM4:Monomorphic epitheliotropic intestinal T-cell lymphoma]]
| |
− | - [[HAEM4:Intestinal T-cell lymphoma, NOS]]
| |
− | ''Hepatosplenic T-cell lymphoma''
| |
− | - [[HAEM4:Hepatosplenic T-cell lymphoma]]
| |
− | ''Anaplastic large cell lymphoma''
| |
− | - [[HAEM4:ALK-positive anaplastic large cell lymphoma]]
| |
− | - [[HAEM4:ALK-negative anaplastic large cell lymphoma]]
| |
− | - [[HAEM4:Breast implant-associated anaplastic large cell lymphoma]]
| |
− | ''Nodal T-follicular helper (TFH) cell lymphoma''
| |
− | - [[HAEM4:Nodal TFH cell lymphoma, angioimmunoblastic-type]]
| |
− | - [[HAEM4:Nodal TFH cell lymphoma, follicular-type]]
| |
− | - [[HAEM4:Nodal TFH cell lymphoma, NOS]]
| |
− | ''Other peripheral T-cell lymphomas''
| |
− | - [[HAEM4:Peripheral T-cell lymphoma, NOS]]
| |
− | ''EBV-positive NK-cell and T-cell lymphomas''
| |
− | - [[HAEM4:EBV-positive nodal T- and NK-cell lymphoma]]
| |
− | - [[HAEM4:Extranodal NK/T-cell lymphoma]]
| |
− | ''EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood''
| |
− | - [[HAEM4:Severe mosquito bite allergy]]
| |
− | - [[HAEM4:Hydroa vacciniforme lymphoproliferative disorder]]
| |
− | - [[HAEM4:Systemic chronic active EBV disease]]
| |
− | - [[HAEM4:Systemic EBV-positive T-cell lymphoma of childhood]]
| |
− | ==Stroma-derived neoplasms of lymphoid tissues==
| |
| | | |
− | '''Mesenchymal dendritic cell neoplasms'''
| + | - [[HAEM4:Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome]] |
− | ''Follicular dendritic cell neoplasms''
| + | - [[HAEM4:Myeloid Leukemia Associated with Down Syndrome]] |
− | - [[HAEM4:Follicular dendritic cell sarcoma]]
| |
− | - [[HAEM4:EBV-positive inflammatory follicular dendritic cell sarcoma]]
| |
− | - [[HAEM4:Fibroblastic reticular cell tumour]]
| |
| | | |
− | '''Myofibroblastic tumours'''
| + | ==Blastic Plasmacytoid Dendritic Cell Neoplasm ([[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
− | ''Myofibroblastic tumour''
| |
− | - [[HAEM4:Intranodal palisaded myofibroblastoma]]
| |
| | | |
− | '''Spleen-specific vascular-stromal tumours'''
| + | *[[HAEM4:Blastic Plasmacytoid Dendritic Cell Neoplasm]] |
− | ''Splenic vascular-stromal tumours''
| + | |
− | - [[HAEM4:Littoral cell angioma]]
| + | ==Acute Leukemias of Ambiguous Lineage (MPAL) ([[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
− | - [[HAEM4:Splenic hamartoma]]
| + | |
− | - [[HAEM4:Sclerosing angiomatoid nodular transformation (SANT) of spleen]]
| + | *[[HAEM4:Acute Leukemias of Ambiguous Lineage]] |
− | ==Genetic tumour syndromes== | + | |
− | - [[HAEM4:Fanconi anaemia]]
| + | - [[HAEM4:Acute Undifferentiated Leukemia]] |
− | - [[HAEM4:Bloom syndrome]]
| + | - [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]] |
− | - [[HAEM4:Ataxia-telangiectasia syndrome]]
| + | - [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]] |
− | - [[HAEM4:RASopathies]]
| + | - [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified]] |
| + | - [[HAEM4:Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]] |
| + | - [[HAEM4:Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types]] |
| + | - [[HAEM4:Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] |
| + | |
| + | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ([[HAEM4:Precursor Lymphoid Neoplasms|Overview Page Link]])== |
| + | |
| + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] |
| + | |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]] |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged|B-ALL with t(v;11q23.3); KMT2A-Rearranged]] |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]] |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy|B-ALL with Hyperdiploidy]] |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy|B-ALL with Hypodiploidy]] |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]] |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]] |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like|B-ALL, BCR-ABL1-Like]] |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with iAMP21|B-ALL with iAMP21]] |
| + | - [[HAEM4:B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified|B-ALL, Not Otherwise Specified]] |
| + | |
| + | *[[HAEM4:T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]] |
| + | |
| + | - [[HAEM4:Early T-Cell Precursor Lymphoblastic Leukemia]] |
| + | - [[HAEM4:NK-Lymphoblastic Leukemia/Lymphoma]] |
| + | |
| + | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ([[HAEM4:Mature B-Cell Neoplasms|Overview Page Link]])== |
| + | |
| + | *[[HAEM4:Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] |
| + | |
| + | - [[HAEM4:Monoclonal B-cell Lymphocytosis]] |
| + | |
| + | *[[HAEM4:B-cell Prolymphocytic Leukemia]] |
| + | |
| + | *[[HAEM4:Splenic Marginal Zone Lymphoma]] |
| + | |
| + | *[[HAEM4:Hairy Cell Leukemia]] |
| + | |
| + | *[[HAEM4:Splenic B-cell Lymphoma/Leukemia, Unclassifiable]] |
| + | |
| + | - [[HAEM4:Splenic Diffuse Red Pulp Small B-cell Lymphoma]] |
| + | - [[HAEM4:Hairy Cell Leukemia Variant]] |
| + | |
| + | *[[HAEM4:Lymphoplasmacytic Lymphoma]] |
| + | |
| + | - [[HAEM4:Waldenstrom Macroglobulinemia]] |
| + | |
| + | *[[HAEM4:IgM Monoclonal Gammopathy of Undetermined Significance]] |
| + | |
| + | *[[HAEM4:Heavy Chain Diseases]] |
| + | |
| + | - [[HAEM4:Mu Heavy Chain Disease]] |
| + | - [[HAEM4:Gamma Heavy Chain Disease]] |
| + | - [[HAEM4:Alpha Heavy Chain Disease]] |
| + | |
| + | *[[HAEM4:Plasma Cell Neoplasms]] |
| + | |
| + | - [[HAEM4:Non-IgM Monoclonal Gammopathy of Undetermined Significance]] |
| + | - [[HAEM4:Plasma Cell Myeloma]] |
| + | - [[HAEM4:Plasma Cell Myeloma Variants]] |
| + | - [[HAEM4:Plasmacytoma]] |
| + | - [[HAEM4:Monoclonal Immunoglobulin Deposition Diseases]] |
| + | - [[HAEM4:Primary Amyloidosis]] |
| + | - [[HAEM4:Light Chain and Heavy Chain Deposition Disease]] |
| + | - [[HAEM4:Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome]] |
| + | - [[HAEM4:POEMS Syndrome]] |
| + | - [[HAEM4:TEMPI Syndrome]] |
| + | |
| + | *[[HAEM4:Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)]] |
| + | |
| + | *[[HAEM4:Nodal Marginal Zone Lymphoma]] |
| + | |
| + | - [[HAEM4:Paediatric Nodal Marginal Zone Lymphoma]] |
| + | |
| + | *[[HAEM4:Follicular Lymphoma]] |
| + | |
| + | - [[HAEM4:Testicular Follicular Lymphoma]] |
| + | - [[HAEM4:In Situ Follicular Neoplasia]] |
| + | - [[HAEM4:Duodenal-Type Follicular Lymphoma]] |
| + | |
| + | *[[HAEM4:Paediatric-Type Follicular Lymphoma]] |
| + | |
| + | *[[HAEM4:Large B-cell Lymphoma with IRF4 Rearrangement]] |
| + | |
| + | *[[HAEM4:Primary Cutaneous Follicle Centre Lymphoma]] |
| + | |
| + | *[[HAEM4:Mantle Cell Lymphoma]] |
| + | |
| + | - [[HAEM4:Leukemic Non-Nodal Mantle Cell Lymphoma]] |
| + | - [[HAEM4:In Situ Mantle Cell Neoplasia]] |
| + | |
| + | *[[HAEM4:Diffuse Large B-cell Lymphoma, Not Otherwise Specified]] |
| + | |
| + | *[[HAEM4:T-cell/Histiocyte-Rich Large B-cell Lymphoma]] |
| + | |
| + | *[[HAEM4:Primary Diffuse Large B-cell Lymphoma of the CNS]] |
| + | |
| + | *[[HAEM4:Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type]] |
| + | |
| + | *[[HAEM4:EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]] |
| + | |
| + | *[[HAEM4:EBV-Positive Mucocutaneous Ulcer]] |
| + | |
| + | *[[HAEM4:Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation]] |
| + | |
| + | - [[HAEM4:Fibrin-Associated Diffuse Large B-cell Lymphoma]] |
| + | |
| + | *[[HAEM4:Lymphomatoid Granulomatosis]] |
| + | |
| + | *[[HAEM4:Primary Mediastinal (Thymic) Large B-cell Lymphoma]] |
| + | |
| + | *[[HAEM4:Intravascular Large B-cell Lymphoma]] |
| + | |
| + | *[[HAEM4:ALK-Positive Large B-cell Lymphoma]] |
| + | |
| + | *[[HAEM4:Plasmablastic Lymphoma]] |
| + | |
| + | *[[HAEM4:Primary Effusion Lymphoma]] |
| + | |
| + | *[[HAEM4:HHV8-Associated Lymphoproliferative Disorders]] |
| + | |
| + | - [[HAEM4:Multicentric Castleman Disease]] |
| + | - [[HAEM4:HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]] |
| + | - [[HAEM4:HHV8-Positive Germinotropic Lymphoproliferative Disorder]] |
| + | |
| + | *[[HAEM4:Burkitt Lymphoma]] |
| + | |
| + | *[[HAEM4:Burkitt-Like Lymphoma with 11q Aberration]] |
| + | |
| + | *[[HAEM4:High-Grade B-cell Lymphoma]] |
| + | |
| + | - [[HAEM4:High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]] |
| + | - [[HAEM4:High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]] |
| + | |
| + | *[[HAEM4:B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] |
| + | |
| + | ==Mature T- and NK-cell Neoplasms ([[HAEM4:Mature T- and NK-cell Neoplasms|Overview Page Link]])== |
| + | |
| + | *[[HAEM4:T-cell Prolymphocytic Leukemia]] |
| + | |
| + | *[[HAEM4:T-cell Large Granular Lymphocytic Leukemia]] |
| + | |
| + | *[[HAEM4:Chronic Lymphoproliferative Disorder of NK Cells]] |
| + | |
| + | *[[HAEM4:Aggressive NK-cell Leukemia]] |
| + | |
| + | *[[HAEM4:EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood]] |
| + | |
| + | - [[HAEM4:Systemic EBV-Positive T-cell Lymphoma of Childhood]] |
| + | - [[HAEM4:Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form]] |
| + | - [[HAEM4:Hydroa Vacciniforme-Like Lymphoproliferative Disorder]] |
| + | - [[HAEM4:Severe Mosquito Bite Allergy]] |
| + | |
| + | *[[HAEM4:Adult T-cell Leukemia/Lymphoma]] |
| + | |
| + | *[[HAEM4:Extranodal NK/T-cell Lymphoma, Nasal Type]] |
| + | |
| + | *[[HAEM4:Intestinal T-cell Lymphoma]] |
| + | |
| + | - [[HAEM4:Enteropathy-Associated T-cell Lymphoma]] |
| + | - [[HAEM4:Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]] |
| + | - [[HAEM4:Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]] |
| + | - [[HAEM4:Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]] |
| + | |
| + | *[[HAEM4:Hepatosplenic T-cell Lymphoma]] |
| + | |
| + | *[[HAEM4:Subcutaneous Panniculitis-Like T-cell Lymphoma]] |
| + | |
| + | *[[HAEM4:Mycosis Fungoides]] |
| + | |
| + | *[[HAEM4:Sézary Syndrome]] |
| + | |
| + | *[[HAEM4:Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]] |
| + | |
| + | - [[HAEM4:Lymphomatoid Papulosis]] |
| + | - [[HAEM4:Primary Cutaneous Anaplastic Large Cell Lymphoma]] |
| + | |
| + | *[[HAEM4:Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes]] |
| + | |
| + | - [[HAEM4:Primary Cutaneous Gamma Delta T-cell Lymphoma]] |
| + | - [[HAEM4:Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma]] |
| + | - [[HAEM4:Primary Cutaneous Acral CD8+ T-cell Lymphoma]] |
| + | - [[HAEM4:Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder]] |
| + | |
| + | *[[HAEM4:Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)]] |
| + | |
| + | *[[HAEM4:Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]] |
| + | |
| + | - [[HAEM4:Angioimmunoblastic T-cell Lymphoma]] |
| + | - [[HAEM4:Follicular T-cell Lymphoma]] |
| + | - [[HAEM4:Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype]] |
| + | |
| + | *[[HAEM4:Anaplastic Large Cell Lymphoma, ALK-Positive]] |
| + | |
| + | *[[HAEM4:Anaplastic Large Cell Lymphoma, ALK-Negative]] |
| + | |
| + | *[[HAEM4:Breast Implant-Associated Anaplastic Large Cell Lymphoma]] |
| + | |
| + | ==Hodgkin Lymphomas ([[HAEM4:Hodgkin Lymphomas|Overview Page Link]])== |
| + | |
| + | *[[HAEM4:Nodular Lymphocyte Predominant Hodgkin Lymphoma]] |
| + | |
| + | *[[HAEM4:Classic Hodgkin Lymphoma]] |
| + | |
| + | - [[HAEM4:Nodular Sclerosis Classic Hodgkin Lymphoma]] |
| + | - [[HAEM4:Lymphocyte-Rich Classic Hodgkin Lymphoma]] |
| + | - [[HAEM4:Mixed Cellularity Classic Hodgkin Lymphoma]] |
| + | - [[HAEM4:Lymphocyte-Depleted Classic Hodgkin Lymphoma]] |
| + | |
| + | ==Immunodeficiency-Associated Lymphoproliferative Disorders ([[HAEM4:Immunodeficiency-Associated Lymphoproliferative Disorders|Overview Page Link]])== |
| + | |
| + | *[[HAEM4:Lymphomas Associated with HIV Infection]] |
| + | |
| + | *[[HAEM4:Post-Transplant Lymphoproliferative Disorders]] |
| + | |
| + | - [[HAEM4:Non-Destructive Post-Transplant Lymphoproliferative Disorders]] |
| + | - [[HAEM4:Polymorphic Post-Transplant Lymphoproliferative Disorders]] |
| + | - [[HAEM4:Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)]] |
| + | - [[HAEM4:Monomorphic B-cell PTLD]] |
| + | - [[HAEM4:Monomorphic T/NK-cell PTLD]] |
| + | - [[HAEM4:Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder]] |
| + | |
| + | *[[HAEM4:Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] |
| + | |
| + | ==Histiocytic and Dendritic Cell Neoplasms ([[HAEM4:Histiocytic and Dendritic Cell Neoplasms|Overview Page Link]])== |
| + | |
| + | *[[HAEM4:Histiocytic Sarcoma]] |
| + | |
| + | *[[HAEM4:Tumors Derived From Langerhans Cells]] |
| + | |
| + | - [[HAEM4:Langerhans Cell Histiocytosis]] |
| + | - [[HAEM4:Langerhans Cell Sarcoma]] |
| + | |
| + | *[[HAEM4:Indeterminate Dendritic Cell Tumour]] |
| + | |
| + | *[[HAEM4:Interdigitating Dendritic Cell Sarcoma]] |
| + | |
| + | *[[HAEM4:Follicular Dendritic Cell Sarcoma]] |
| + | |
| + | - [[HAEM4:Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma]] |
| + | |
| + | *[[HAEM4:Fibroblastic Reticular Cell Tumor]] |
| + | |
| + | *[[HAEM4:Disseminated Juvenile Xanthogranuloma]] |
| + | |
| + | *[[HAEM4:Erdheim-Chester Disease]] |
| + | |
| + | ==Notes== |
| + | <nowiki>*</nowiki>The hierarchical tumour classification structure displayed on this page is reproduced from the [https://tumourclassification.iarc.who.int/welcome/ WHO Classification of Tumours] with permission from the copyright holder, ©International Agency for Research on Cancer. |